Skin Inc

Physiology Sponsored by

Email This Item!
Increase Text Size

National Psoriasis Foundation Doubles Number of Researchers Studying Psoriasis

Posted: July 10, 2014

National Psoriasis Foundation (NPF) will double the number of researchers studying psoriasis and psoriatic arthritis while also cutting in half the number of people who say these chronic conditions are a problem in their daily lives as part of its new five-year strategic plan and mission to cure psoriatic disease and improve the lives of those affected.

"This is the most aggressive, results-driven strategic plan the National Psoriasis Foundation has undertaken," said Pete Redding, vice chair, National Psoriasis Foundation Board of Directors and chair of the NPF Strategic Plan Committee. "It puts the person living with psoriatic disease at the center of all of our goals and demonstrates the Psoriasis Foundation commitment to improving the lives of millions of people with psoriasis and psoriatic arthritis."

The Psoriasis Foundation will accelerate scientific research to cure psoriasis—the most common autoimmune disease in the country, affecting as many as 7.5 million Americans—and psoriatic arthritis—an inflammatory joint and tendon disease that occurs in up to one in three people with psoriasis—and work to dramatically better the health of people with psoriatic disease. The Foundation will accomplish these goals by:

To learn more about the NPF strategic plan, visit www.psoriasis.org/strategic-plan.